Stockreport

Seneca Biopharma Reports Receipt of Warrant Exercise Proceeds

Seneca Biopharma, Inc.  (SNCA) 
PDF GERMANTOWN, Md., May 22, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of h [Read more]